Esther Krofah
Showing 16–19 of 19 transcripts.
- Milken Institute1h 1m
Prevention and Innovation for a Healthier Tomorrow | Global Conference 2024
Esther Krofah, Robert Bradway, David Feinberg, Karen Knudsen, Meena Seshamani
Representatives from CMS, the American Cancer Society, Oracle Health, and Amgen convened to address the U.S. healthcare system's inefficiencies, noting that while the sector consumes 20% of GDP, chronic disease prevalence and administrative friction continue to drive costs while outcomes remain misaligned. Key strategies outlined include shifting Medicare toward value-based care with a $2,000 prescription cap, leveraging AI tools like the Oracle Digital Clinical Assistant to reduce physician administrative burdens, and advocating for federal reimbursement of multi-cancer early detection to improve survival rates. The panelists reached a consensus that the current fragmented structure is impoding and requires fundamental structural reforms rather than incremental solutions to successfully integrate prevention, innovation, and data interoperability.
- Milken Institute1h 16m
Closing Gaps in Health and Health Care | Future of Health Summit 2023
Esther Krofah, AmirAli Talasaz, Susan Barlow, Meg Tirrell, Jaewon Ryu, Ashwin Vasan, Hubertus von Baumbach, Angela F. Williams, Ray Broughan, Bob Cramer, Diane Tai
The 2023 Milken Institute Future of Health Summit convened sector leaders to address the U.S. life expectancy decline and widening inequities despite record spending of over $4.1 trillion annually. Key initiatives announced include the Aging Innovation Collaborative with $3 million in seed funding, New York City's "Healthy NYC" strategy targeting premature death, and a renewed focus on shifting from fee-for-service models to preventive care through public-private partnerships. Experts emphasized that closing the gap requires an industrial health policy to align regulatory updates, leverage AI for early detection, and rebuild community trust through equitable data sharing and resource integration.
- Milken Institute1h 2m
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
Esther Krofah, Francis Collins, Richard Moscicki, Ellen Sigal, Janet Woodcock
Hosted by Faster Cures, a webinar convened NIH officials and industry leaders to analyze the COVID-19 pandemic's acceleration of biomedical innovation, highlighting achievements such as the ACTIV partnership's master protocols and the RADx initiative's diagnostic scaling. The discussion detailed how the crisis forced a shift toward competitive collaboration, decentralized trials, and the successful achievement of diverse vaccine trial enrollment, while simultaneously exposing critical infrastructure gaps in clinical trial execution and real-world data integration. Panelists concluded with a consensus that emergency-driven reforms must be institutionalized through permanent policy changes and public-private partnerships to sustain preparedness for future health threats.
- Milken Institute56 min
Superbugs: Avoiding an Existential Threat to Humanity
Esther Krofah, Valeria Bortolaia, Ron Daniels, Peter Jackson, Peter Piot, Lance Price, Sneha Kemka
This analysis details the critical global escalation of antimicrobial resistance, which currently causes 700,000 annual deaths and threatens to reach 10 million by 2050 without urgent intervention. The event highlights a pharmaceutical market failure where major drug withdrawals have shifted innovation to undercapitalized SMEs, necessitating new economic incentives like the UK's pilot pull mechanism to fund R&D. Strategic solutions prioritize infection control, agricultural bans on growth promoters, and precision diagnostics to bridge the gap between scientific discovery and clinical application.